FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318930731> ?p ?o ?g. }

• W4318930731 endingPage "S374" @default.
• W4318930731 startingPage "S371" @default.
• W4318930731 abstract "Bleeding complications are not uncommon after breast reduction surgery, and recently, tranexamic acid (TXA) as an antifibrinolytic agent has been used in various surgical specialties as a way to minimizes such adverse outcomes. We elected to evaluate the effectiveness of intravenous (IV) intraoperative TXA in reduction mammoplasty patients.This is a retrospective chart review of clinical charts of all patients who received reduction mammoplasty by a single surgeon at Emory University Hospital or its affiliated Aesthetic Center from January 1, 2020, to March 1, 2022. Seventy-four consecutive breast reduction patients received 1-g IV TXA intraoperatively compared with 117 consecutive controls. The outcome of interest included 30-day postoperative bleeding complications.There was no significant difference in age ( P = 0.92), body mass index ( P = 0.98), percentage of smokers ( P = 0.56), operating time ( P = 0.87), estimated blood loss ( P = 0.90), or weight removed ( P = 0.98) between patients in each arm. There were 19 bleeding events (16.2%) in the non-TXA arm compared with 1 bleeding event (1.4%) in the TXA arm ( P = 0.0143). Of the 19, 6 (5.1%) were major events, and 13 were minor events (11.1%); the only bleeding event in the TXA arm was minor. Number needed to treat all bleeding events with use of TXA was 7, and the number needed to treat minor hematomas was 11. There was no significant difference in the rate of seroma, wound healing complications, infection, or nipple necrosis between the 2 arms ( P > 0.05).The use of IV TXA is a safe and effective way to reduce hematoma rates in patients receiving reduction mammoplasty." @default.
• W4318930731 created "2023-02-03" @default.
• W4318930731 creator A5019795341 @default.
• W4318930731 creator A5030203819 @default.
• W4318930731 creator A5030913391 @default.
• W4318930731 creator A5036626964 @default.
• W4318930731 date "2022-12-08" @default.
• W4318930731 modified "2023-10-16" @default.
• W4318930731 title "The Usage of Intravenous Tranexamic Acid in Reduction Mammaplasty Safely Reduces Hematoma Rates" @default.
• W4318930731 cites W1889186786 @default.
• W4318930731 cites W1976511219 @default.
• W4318930731 cites W1976965406 @default.
• W4318930731 cites W1978375149 @default.
• W4318930731 cites W1978822123 @default.
• W4318930731 cites W2092477906 @default.
• W4318930731 cites W2098149785 @default.
• W4318930731 cites W2262616197 @default.
• W4318930731 cites W2263376891 @default.
• W4318930731 cites W2290313280 @default.
• W4318930731 cites W2317577142 @default.
• W4318930731 cites W2322962462 @default.
• W4318930731 cites W2413550491 @default.
• W4318930731 cites W2514036270 @default.
• W4318930731 cites W2556293386 @default.
• W4318930731 cites W2759789986 @default.
• W4318930731 cites W2769916425 @default.
• W4318930731 cites W2802303545 @default.
• W4318930731 cites W2803157359 @default.
• W4318930731 cites W2911449733 @default.
• W4318930731 cites W2945103832 @default.
• W4318930731 cites W2969345619 @default.
• W4318930731 cites W2971722357 @default.
• W4318930731 cites W2985939526 @default.
• W4318930731 cites W2994746465 @default.
• W4318930731 cites W2998346198 @default.
• W4318930731 cites W3013089033 @default.
• W4318930731 cites W3033656282 @default.
• W4318930731 cites W3034636527 @default.
• W4318930731 cites W3042030418 @default.
• W4318930731 cites W3094000599 @default.
• W4318930731 cites W3130544896 @default.
• W4318930731 cites W3136942564 @default.
• W4318930731 cites W3150590521 @default.
• W4318930731 cites W4205199291 @default.
• W4318930731 cites W4220657196 @default.
• W4318930731 cites W4252648840 @default.
• W4318930731 cites W4367140108 @default.
• W4318930731 doi "https://doi.org/10.1097/sap.0000000000003296" @default.
• W4318930731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36729851" @default.
• W4318930731 hasPublicationYear "2022" @default.
• W4318930731 type Work @default.
• W4318930731 citedByCount "0" @default.
• W4318930731 crossrefType "journal-article" @default.
• W4318930731 hasAuthorship W4318930731A5019795341 @default.
• W4318930731 hasAuthorship W4318930731A5030203819 @default.
• W4318930731 hasAuthorship W4318930731A5030913391 @default.
• W4318930731 hasAuthorship W4318930731A5036626964 @default.
• W4318930731 hasConcept C121608353 @default.
• W4318930731 hasConcept C126322002 @default.
• W4318930731 hasConcept C141071460 @default.
• W4318930731 hasConcept C197934379 @default.
• W4318930731 hasConcept C2778579461 @default.
• W4318930731 hasConcept C2779409168 @default.
• W4318930731 hasConcept C2779637338 @default.
• W4318930731 hasConcept C2779662492 @default.
• W4318930731 hasConcept C2779663748 @default.
• W4318930731 hasConcept C2781037480 @default.
• W4318930731 hasConcept C2781436528 @default.
• W4318930731 hasConcept C2910018596 @default.
• W4318930731 hasConcept C2991743468 @default.
• W4318930731 hasConcept C42219234 @default.
• W4318930731 hasConcept C530470458 @default.
• W4318930731 hasConcept C71924100 @default.
• W4318930731 hasConcept C81182388 @default.
• W4318930731 hasConceptScore W4318930731C121608353 @default.
• W4318930731 hasConceptScore W4318930731C126322002 @default.
• W4318930731 hasConceptScore W4318930731C141071460 @default.
• W4318930731 hasConceptScore W4318930731C197934379 @default.
• W4318930731 hasConceptScore W4318930731C2778579461 @default.
• W4318930731 hasConceptScore W4318930731C2779409168 @default.
• W4318930731 hasConceptScore W4318930731C2779637338 @default.
• W4318930731 hasConceptScore W4318930731C2779662492 @default.
• W4318930731 hasConceptScore W4318930731C2779663748 @default.
• W4318930731 hasConceptScore W4318930731C2781037480 @default.
• W4318930731 hasConceptScore W4318930731C2781436528 @default.
• W4318930731 hasConceptScore W4318930731C2910018596 @default.
• W4318930731 hasConceptScore W4318930731C2991743468 @default.
• W4318930731 hasConceptScore W4318930731C42219234 @default.
• W4318930731 hasConceptScore W4318930731C530470458 @default.
• W4318930731 hasConceptScore W4318930731C71924100 @default.
• W4318930731 hasConceptScore W4318930731C81182388 @default.
• W4318930731 hasIssue "6S" @default.
• W4318930731 hasLocation W43189307311 @default.
• W4318930731 hasLocation W43189307312 @default.
• W4318930731 hasOpenAccess W4318930731 @default.
• W4318930731 hasPrimaryLocation W43189307311 @default.
• W4318930731 hasRelatedWork W141594980 @default.
• W4318930731 hasRelatedWork W1911590278 @default.

• next